melanocortin receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-15. Numbers and descriptions here follow the published literature rather than marketing material.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Freely soluble in water | Dissolves readily in aqueous buffer |
| Typical storage temperature | -20 °C or below | Protect from light and moisture |
| Typical analytical method | Reversed-phase HPLC and LC-MS | Purity estimate plus mass confirmation |
| Unit of measure | Milligram per vial | Content varies by vendor |
Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
== Medical uses == Atomoxetine is sold under the brand name Strattera and was first approved for medical use in the United States in 2002. Its indication is for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents and adults. Atomoxetine selectively inhibits norepinephrine reuptake by blocking the presynaptic norepinephrine transporter (NET) in the brain. Research has suggested that it also inhibits the reuptake of serotonin by binding to the selective serotonin transporter. However it is not known whether the therapeutic effects of atomoxetine is due to its blockage of the NET or both norepinephrine- and serotonin transporters. Reboxetine, sold under the brand name Edronax, is a selective norepinephrine reuptake inhibitor and acts by binding to the NET and blocking the reuptake of norepinephrine in the extracellular fluids. Its indication is for acute treatment of depression or major depression disorder. Reboxetine was first approved for marketing in Europe in 1997, however, in the United States its application for approval was rejected.
Animation – Dispatch Artistic Achievement – Death Stranding 2: On the Beach Audio Achievement – Dispatch Best Game – Clair Obscur: Expedition 33 British Game – Atomfall Debut Game – Clair Obscur: Expedition 33 Evolving Game – No Man's Sky Family – Lego Party Game Beyond Entertainment – Despelote Game Design – Blue Prince Multiplayer – ARC Raiders Music – Ghost of Yōtei Narrative – Kingdom Come: Deliverance II New Intellectual Property – South of Midnight Performer in a Leading Role – Jennifer English as Maelle in Clair Obscur: Expedition 33 Performer in a Supporting Role – Jeffrey Wright as Chase in Dispatch Technical Achievement – Ghost of Yōtei
=== Parasitic infections === Parasites are a diverse group of pathogens with significant health implications. Parasitic diseases can be transmitted through blood (e.g. malaria), contaminated water or food (e.g. Trichinella spiralis, Giardia duodenalis), penetration of skin or mucous membranes (e.g. Strongyloidiasis), and direct contact between hosts (e.g. Trichomonas vaginalis). Mast cells (MCs) tend to be located in strategic positions such as the subepithelial layers of skin, the respiratory system, the gastrointestinal tract, the genitourinary tract, and around blood vessels or nerves. Interactions between parasite and host are complex, involving parasite evasion strategies, host defense mechanisms, and continuous adaptation of both. Due to their strategic location in the host-environment interface MCs can provide rapid response capability. MCs can be activated in a parasite-specific manner through the detection of highly specialized molecular patterns related to pathogens (PAMPs) and microbes (MAMPs). The most characteristic feature of the immune system's response to parasite attack is the binding of immunoglobulin E (IgE) to the FcεRI receptor, which triggers MC degranulation and the release of mediators. These, in turn, trigger IgE-mediated type 2 responses, characterized by signaling from IL-4, IL-5, and IL-13. In responding to infection, mast cells orchestrate both first-line innate immune responses and adaptive immune processes in a variety of cell types.
He also established that the acid was readily soluble in cold ether and absolute alcohol, and unlike lichesterinic acid, could reduce potassium permanganate solution in the cold. Further work by Böhme in 1903 showed that the compound had a specific rotation of +29.3° and could decompose under reduced pressure (40mm) to form C18H32O3. Later work by Asano and Asahina established that natural protolichesterinic acid actually has a negative specific rotation ([α]D = −12.71°), indicating it is the (−)-(2S,3R) enantiomer, while the material studied by Zopf and Böhme was the (+)-(2R,3S) form.
Sources: en.wikipedia.org
In coalition-occupied Iraqi territory, a peace conference was held where a ceasefire agreement was negotiated and signed by both sides. At the conference, Iraq was authorized to fly armed helicopters on their side of the temporary border, ostensibly for government transit due to the damage done to civilian infrastructure. Soon after, these helicopters and much of Iraq's military were used to fight an uprising in the south. On March 1, 1991, one day after the Gulf War ceasefire, a revolt broke out in Basra against the Iraqi government. The uprising spread within days to all of the largest Shia cities in southern Iraq: Najaf, Amarah, Diwaniya, Hilla, Karbala, Kut, Nasiriyah and Samawah. The rebellions were encouraged by an airing of "The Voice of Free Iraq" on 24 February 1991, which was broadcast from a CIA-run radio station out of Saudi Arabia. The Arabic service of the Voice of America supported the uprising by stating that the rebellion was well supported, and that they would soon be liberated from Saddam. In the north, Kurdish leaders took American statements that they would support an uprising to heart, and began fighting, hoping to trigger a coup d'état. However, when no US support came, Iraqi generals remained loyal to Saddam and brutally crushed the Kurdish uprising and the uprising in the south. Millions of Kurds fled across the mountains to Turkey and Kurdish areas of Iran.
Leconotide (INN; development codes CNSB004 and AM336; also known as ω-conotoxin CVID) is an ω-conotoxin peptide isolated from the venom of Conus catus which is under investigation as an analgesic drug for the treatment of pain conditions. It acts as an N-type voltage-gated calcium channel (Cav2.2) blocker and is highly selective for this channel over the related P/Q-type voltage-gated calcium channel (Cav2.1). Relative to ziconotide, leconotide is advantageous in that it is significantly less toxic, and for that reason can be administered intravenously as opposed to via intrathecal injection.
Irritable bowel syndrome (IBS) Celiac disease. Inflammatory bowel diseases. Exercise-induced gastrointestinal syndrome and exercise-associated gastrointestinal symptoms. Small intestinal bacterial overgrowth. The low-FODMAP diet is intended to be used only after a full medical evaluation. This ensures correct diagnosis and treatment. Use of a low-FODMAP diet without medical advice can lead to serious health risks, including nutritional deficiencies and misdiagnosis of celiac disease. Sometimes the diet is used in phases. Firstly, FODMAPs below the threshold value are eliminated from the diet (restriction phase). The restriction phase does not usually last more than six weeks. After this stage, products that were eliminated are re-introduced into the diet one at a time. This allows for assessment of the effects of different types of FODMAP on the individual. The final stage involves creation of a long-term diet based on the evidence collected from the previous stage.
Sources: en.wikipedia.org
The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.
Reversed-phase liquid chromatography estimates purity, and mass spectrometry confirms molecular mass. Together they distinguish the intended peptide from truncated or modified forms. Sequence-level confirmation may use tandem mass spectrometry or amino acid analysis.
Because it is not made under pharmaceutical standards, purity and content can vary between vendors and batches. Independent testing has documented labeling discrepancies. A certificate of analysis from an accredited laboratory offers more assurance than a vendor's own claim.
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.